Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.

BACKGROUND: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. OBJECTIVE: The objectives were to assess the association between plasma phospholipid fatty acids a...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Crowe, F, Allen, N, Appleby, P, Overvad, K, Aardestrup, I, Johnsen, N, Tjønneland, A, Linseisen, J, Kaaks, R, Boeing, H, Kröger, J, Trichopoulou, A, Zavitsanou, A, Trichopoulos, D, Sacerdote, C, Palli, D, Tumino, R, Agnoli, C, Kiemeney, L, Bueno-de-Mesquita, H, Chirlaque, MD, Ardanaz, E, Larrañaga, N, Quirós, JR, Sánchez, M
Format: Journal article
Język:English
Wydane: 2008
_version_ 1826298756736221184
author Crowe, F
Allen, N
Appleby, P
Overvad, K
Aardestrup, I
Johnsen, N
Tjønneland, A
Linseisen, J
Kaaks, R
Boeing, H
Kröger, J
Trichopoulou, A
Zavitsanou, A
Trichopoulos, D
Sacerdote, C
Palli, D
Tumino, R
Agnoli, C
Kiemeney, L
Bueno-de-Mesquita, H
Chirlaque, MD
Ardanaz, E
Larrañaga, N
Quirós, JR
Sánchez, M
author_facet Crowe, F
Allen, N
Appleby, P
Overvad, K
Aardestrup, I
Johnsen, N
Tjønneland, A
Linseisen, J
Kaaks, R
Boeing, H
Kröger, J
Trichopoulou, A
Zavitsanou, A
Trichopoulos, D
Sacerdote, C
Palli, D
Tumino, R
Agnoli, C
Kiemeney, L
Bueno-de-Mesquita, H
Chirlaque, MD
Ardanaz, E
Larrañaga, N
Quirós, JR
Sánchez, M
author_sort Crowe, F
collection OXFORD
description BACKGROUND: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. OBJECTIVE: The objectives were to assess the association between plasma phospholipid fatty acids and risk of total prostate cancer by stage and grade. DESIGN: This was a nested case-control analysis of 962 men with a diagnosis of prostate cancer after a median follow-up time of 4.2 y and 1061 matched controls who were taking part in the European Prospective Investigation into Cancer and Nutrition. The fatty acid composition of plasma phospholipids was measured by gas chromatography, and the risk of prostate cancer was estimated by using conditional logistic regression with adjustment for lifestyle variables. RESULTS: We found a positive association between palmitic acid and risk of total, localized, and low-grade prostate cancer. The risk of prostate cancer for men in the highest quintile compared with the lowest quintile of palmitic acid was 1.47 (95% CI: 0.97, 2.23; P for trend = 0.032). We found an inverse association between stearic acid and the risk of total, localized, and low-grade prostate cancer; men in the highest quintile of stearic acid had a relative risk of 0.77 (95% CI: 0.56, 1.06; P for trend = 0.03). There were significant positive associations between myristic, alpha-linolenic, and eicosapentaenoic acids and risk of high-grade prostate cancer. CONCLUSION: The associations between palmitic, stearic, myristic, alpha-linolenic, and eicosapentaenoic acids and prostate cancer risk may reflect differences in intake or metabolism of these fatty acids between the precancer cases and controls and should be explored further.
first_indexed 2024-03-07T04:51:40Z
format Journal article
id oxford-uuid:d52d9321-d69b-44a5-bad3-5dc1279e6ec6
institution University of Oxford
language English
last_indexed 2024-03-07T04:51:40Z
publishDate 2008
record_format dspace
spelling oxford-uuid:d52d9321-d69b-44a5-bad3-5dc1279e6ec62022-03-27T08:24:12ZFatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d52d9321-d69b-44a5-bad3-5dc1279e6ec6EnglishSymplectic Elements at Oxford2008Crowe, FAllen, NAppleby, POvervad, KAardestrup, IJohnsen, NTjønneland, ALinseisen, JKaaks, RBoeing, HKröger, JTrichopoulou, AZavitsanou, ATrichopoulos, DSacerdote, CPalli, DTumino, RAgnoli, CKiemeney, LBueno-de-Mesquita, HChirlaque, MDArdanaz, ELarrañaga, NQuirós, JRSánchez, MBACKGROUND: Plausible biological mechanisms underlie possible associations between fatty acids in blood and risk of prostate cancer; epidemiologic evidence for an association, however, is inconsistent. OBJECTIVE: The objectives were to assess the association between plasma phospholipid fatty acids and risk of total prostate cancer by stage and grade. DESIGN: This was a nested case-control analysis of 962 men with a diagnosis of prostate cancer after a median follow-up time of 4.2 y and 1061 matched controls who were taking part in the European Prospective Investigation into Cancer and Nutrition. The fatty acid composition of plasma phospholipids was measured by gas chromatography, and the risk of prostate cancer was estimated by using conditional logistic regression with adjustment for lifestyle variables. RESULTS: We found a positive association between palmitic acid and risk of total, localized, and low-grade prostate cancer. The risk of prostate cancer for men in the highest quintile compared with the lowest quintile of palmitic acid was 1.47 (95% CI: 0.97, 2.23; P for trend = 0.032). We found an inverse association between stearic acid and the risk of total, localized, and low-grade prostate cancer; men in the highest quintile of stearic acid had a relative risk of 0.77 (95% CI: 0.56, 1.06; P for trend = 0.03). There were significant positive associations between myristic, alpha-linolenic, and eicosapentaenoic acids and risk of high-grade prostate cancer. CONCLUSION: The associations between palmitic, stearic, myristic, alpha-linolenic, and eicosapentaenoic acids and prostate cancer risk may reflect differences in intake or metabolism of these fatty acids between the precancer cases and controls and should be explored further.
spellingShingle Crowe, F
Allen, N
Appleby, P
Overvad, K
Aardestrup, I
Johnsen, N
Tjønneland, A
Linseisen, J
Kaaks, R
Boeing, H
Kröger, J
Trichopoulou, A
Zavitsanou, A
Trichopoulos, D
Sacerdote, C
Palli, D
Tumino, R
Agnoli, C
Kiemeney, L
Bueno-de-Mesquita, H
Chirlaque, MD
Ardanaz, E
Larrañaga, N
Quirós, JR
Sánchez, M
Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
title Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
title_full Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
title_fullStr Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
title_full_unstemmed Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
title_short Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition.
title_sort fatty acid composition of plasma phospholipids and risk of prostate cancer in a case control analysis nested within the european prospective investigation into cancer and nutrition
work_keys_str_mv AT crowef fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT allenn fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT applebyp fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT overvadk fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT aardestrupi fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT johnsenn fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tjønnelanda fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT linseisenj fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kaaksr fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT boeingh fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT krogerj fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT trichopouloua fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT zavitsanoua fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT trichopoulosd fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT sacerdotec fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT pallid fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT tuminor fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT agnolic fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT kiemeneyl fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT buenodemesquitah fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT chirlaquemd fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT ardanaze fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT larranagan fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT quirosjr fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition
AT sanchezm fattyacidcompositionofplasmaphospholipidsandriskofprostatecancerinacasecontrolanalysisnestedwithintheeuropeanprospectiveinvestigationintocancerandnutrition